David Song
Podiatrist · Franklin, TNNPI 1518078039
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,514 of the $3,641 with a category attached, or 69.0%. 24 manufacturers reported payments, led by Paragon 28, Inc. at 38.2% of the total. Reporting peaked in 2019 at $2,002 and has fallen 97.4% since, to $51 in 2025.
Across 59 payments — averaging $61.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$1K
- Stryker$521
- Amgen$298
- Smith+Nephew$218
- Nevro Corp.$179
- Kerecis Limited$156
- plus $880 from 18 others
What the payments were for
- Travel & lodging$1,12731%
- Food & beverage$2,51469%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 4 | $1,390 |
| Stryker | 4 | $521 |
| Amgen | 12 | $298 |
| Smith+Nephew | 6 | $218 |
| Nevro Corp. | 3 | $179 |
| Kerecis Limited | 2 | $156 |
| Triad Life Sciences Inc. | 2 | $151 |
| Organogenesis Inc. | 7 | $140 |
| Orthofix Medical, Inc. | 3 | $112 |
| Alkermes, Inc. | 1 | $98 |
| Convatec Inc. | 1 | $87 |
| Paratek Pharmaceuticals, Inc. | 2 | $40 |
| Medtronic | 1 | $33 |
| Johnson & Johnson | 1 | $30 |
| Treace Medical Concepts, Inc. | 1 | $26 |
| Zimmer Biomet | 1 | $25 |
| Arthrosurface Incorporated | 1 | $21 |
| KCI USA, Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Mimedx Group, Inc. | 1 | $19 |
| Arteriocyte Medical Systems, Inc. | 1 | $19 |
| Advanced Oxygen Therapy Inc. | 1 | $16 |
| Merck | 1 | $12 |
| Dynasplint Systems Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUGMENT INJECTABLE$303
- T2$174
- VALOR$174
- SALVATION$167
- Omnia$143
- InnovaMatrix AC$136
- KRYSTEXXA$121
- Kerecis Omega3 Wound$119
- REGRANEX$117
How this compares
$3,641 in reported general payments places this provider in the 70th percentile of 105 podiatrist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 25 | $55 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Franklin
- Keith LuperFranklin$1K
- Jeffrey LovelandSparta$809K
- Michael KingNashville$190K
- Penninah KumarMt Juliet$72K
- James HarrisTrenton$49K
- Matthew NeuhausSmyrna$33K
- Paul HutchisonMemphis$17K
- Sam BazrafshanChattanooga$16K
- Abshan MalikKnoxville$13K
- Christopher HendrixBartlett$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.